PROTEINATOR: Web-UI exploring repurposing hypotheses of PROTEIN InhibiTORs based on protein interactions
Tangadu, S.; Shankar, S.; Varanasi, B. V.; Athri, P.
Show abstract
PROTEINATOR is the first version of a staggered, multi-paradigm and extensible drug repurposing platform, focusing on a novel data analytic and integration strategy to find repurposing candidates that have potential to modulate targets through protein-protein interactions. The UI was created as an explorer to find indirect drugs for a protein of interest. PROTEINATOR is developed as a web application that lets researchers search for alternate drugs for a protein of interest, based on the proteins direct interaction with a another druggable protein. This unique tool provides researchers exploring specific implicated protein(s) (in the context of drug development), alternate, plausible routes to modulation by listing proteins that interact with the protein of interest that have reported inhibitors. It is a search engine to identify indirect drugs through connecting various databases, thus avoiding multiple steps and avoiding any manual errors. Using a representative set of databases, 112083 number of indirect drug interactions are discovered that are potential modulators of proteins, detailed annotations of which are provided in the UI. PROTEINATOR is freely available at http://www.proteinator.in.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Design and application of a knowledge network for automatic prioritization of drug mechanisms 94%
- Attention-based approach to predict drug-target interactions across seven target superfamilies 94%
- DTI-Voodoo: machine learning over interaction networks and ontology-based background knowledge predicts drug-target interactions 93%
Similar papers in this journal
- Biclique extension as an effective approach to predict novel interaction partners in metabolic compound-protein interaction networks. 93%
- Improving classification of correct and incorrect protein-protein docking models by augmenting the training set 93%
- ACDA: Implementation of an Augmented Drug Synergy Prediction Algorithm 93%
Similar papers in this journal
Similar papers in this journal
- Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations 94%
- DrugForm-DTA: Towards real-world drug-target binding Affinity Model 93%
- Getting to know each other: PPIMem, a novel approach for predicting transmembrane protein-protein complexes 93%
Similar papers in this journal
- Retro Drug Design: From Target Properties to Molecular Structures 94%
- Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening 93%
- The use of a graph database is a complementary approach to a classical similarity search for identifying commercially available fragment merges 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.